Canned Pacific Salmon Deviating From Identity Standard; Amendment of Temporary Marketing Permit, 77468-77469 [2020-26533]

Download as PDF 77468 Federal Register / Vol. 85, No. 232 / Wednesday, December 2, 2020 / Notices being given for this meeting due to the exceptional circumstances of the COVID–19 pandemic and rapidly evolving COVID–19 vaccine development and regulatory processes. The Secretary of Health and Human Services has determined that COVID–19 is a Public Health Emergency. A notice of this ACIP meeting has also been posted on CDC’s ACIP website at: https:// www.cdc.gov/vaccines/acip/. In addition, CDC has sent notice of this ACIP meeting by email to those who subscribe to receive email updates about ACIP. Purpose: The committee is charged with advising the Director, CDC, on the use of immunizing agents. In addition, under 42 U.S.C. 1396s, the committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children (VFC) program, along with schedules regarding dosing interval, dosage, and contraindications to administration of vaccines. Further, under provisions of the Affordable Care Act, section 2713 of the Public Health Service Act, immunization recommendations of the ACIP that have been approved by the Director of the Centers for Disease Control and Prevention and appear on CDC immunization schedules must be covered by applicable health plans. Matters to be Considered: The agenda will include discussions on COVID–19 vaccine allocation. A recommendation vote is scheduled. Agenda items are subject to change as priorities dictate. For more information on the meeting agenda visit https://www.cdc.gov/ vaccines/acip/meetings/meetingsinfo.html. Meeting Information: The meeting will be webcast live via the World Wide Web; for more information on ACIP please visit the ACIP website: https:// www.cdc.gov/vaccines/acip/. Public Participation Interested persons or organizations are invited to participate by submitting written views, recommendations, and data. Please note that comments received, including attachments and other supporting materials are part of the public record and are subject to public disclosure. Do not include any information in your comment or supporting materials that you consider confidential or inappropriate for public disclosure. If you include your name, contact information, or other information that identifies you in the body of your comments, that information will be on public display. CDC will review all submissions and VerDate Sep<11>2014 17:39 Dec 01, 2020 Jkt 253001 may choose to redact, or withhold, submissions containing private or proprietary information such as Social Security numbers, medical information, inappropriate language, or duplicate/ near duplicate examples of a mass-mail campaign. CDC will carefully consider all comments submitted into the docket. CDC does not accept comment by email. Written Public Comment: Written comments must be received on or before December 3, 2020. Oral Public Comment: This meeting will include time for members of the public to make an oral comment. Oral public comment will occur before any scheduled votes including all votes relevant to the ACIP’s Affordable Care Act and Vaccines for Children Program roles. Priority will be given to individuals who submit a request to make an oral public comment before the meeting according to the procedures below. Procedure for Oral Public Comment: All persons interested in making an oral public comment at the December 1, 2020 ACIP meeting must submit a request at https://www.cdc.gov/vaccines/ acip/meetings/ no later than 11:59 p.m., EST, November 30, 2020 according to the instructions provided. If the number of persons requesting to speak is greater than can be reasonably accommodated during the scheduled time, CDC will conduct a lottery to determine the speakers for the scheduled public comment session. CDC staff will notify individuals regarding their request to speak by email by 12:00 p.m., EST, December 1, 2020. To accommodate the significant interest in participation in the oral public comment session of ACIP meetings, each speaker will be limited to 3 minutes, and each speaker may only speak once per meeting. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2020–26587 Filed 11–30–20; 11:15 am] BILLING CODE 4163–18–P PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–1987–P–0074] Canned Pacific Salmon Deviating From Identity Standard; Amendment of Temporary Marketing Permit AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is amending Bumble Bee Seafoods Inc.’s temporary permit to market test canned skinless and boneless chunk salmon packed in water that contains sodium tripolyphosphate to inhibit protein curd formation during retorting. The temporary permit is amended to add an additional manufacturing location. This amendment will allow the applicant to continue to test market the test product and collect data on consumer acceptance of the test product. FOR FURTHER INFORMATION CONTACT: Marjan Morravej, Center for Food Safety and Applied Nutrition (HFS–820), Food and Drug Administration, 5001 Campus Dr., College Park, MD 20740, 240–402– 2371. SUPPLEMENTARY INFORMATION: In the Federal Register of July 13, 1987 (52 FR 26186), we issued a notice announcing that we had issued a temporary permit to Bumble Bee Seafoods, Inc., San Diego, CA 92123, to market test products identified as canned skinless and boneless chunk salmon packed in water and containing added sodium tripolyphosphate to inhibit protein curd formation during retorting. The permit allowed for the test product to be manufactured at a plant located in Petersburg, AK. We issued the permit to facilitate market testing of products that deviate from the requirements of the standard of identity for canned Pacific salmon in 21 CFR 161.170, which were issued under section 401 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 341). In the Federal Register of April 8, 1988 (53 FR 11710), we issued a notice announcing that we had amended the temporary permit to permit the test product be manufactured at one additional plant, Chugach Alaska Fisheries, Inc., Ocean Dock Rd., Cordova, AK 99574. In the Federal Register of September 6, 1988 (53 FR 34354), we issued another notice announcing that we were extending the expiration date of the permit to either the effective date of a SUMMARY: E:\FR\FM\02DEN1.SGM 02DEN1 77469 Federal Register / Vol. 85, No. 232 / Wednesday, December 2, 2020 / Notices final rule for any proposal to amend the standard of identity for canned Pacific salmon that may result from the National Food Processors Association’s petition, submitted on behalf of Bumble Bee Seafoods, Inc., and other salmon packers holding temporary permits, or 30 days after termination of such proposal. In the Federal Register of April 24, 2020 (85 FR 23047), we issued a notice announcing that we amended the temporary permit to allow for the canned skinless and boneless chunk salmon packed in water with or without sodium tripolyphosphate and to allow the test product to be manufactured only at one plant, Pataya Food Industries Ltd., located at 90/6 Moo 7, Settakit Road, Tambol Tarsai, Amphur Maung, Samutsakorn 74000, Thailand. Under our regulations at 21 CFR 130.17(f), we are amending the temporary permit issued to Bumble Bee Seafoods, Inc., to allow the test product to be manufactured at an additional plant, RS Cannery Company Limited, located at 255/1 Industrial Soi 3, Bangpoo Industrial Estate, Samutprakarn 10280, Thailand. All other conditions and terms of this permit remain the same. Dated: November 23, 2020. Lauren K. Roth, Acting Principal Associate Commissioner for Policy. [FR Doc. 2020–26533 Filed 12–1–20; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket Nos. FDA–2013–N–1119; FDA– 2010–N–0622; FDA–2011–N–0016; FDA– 2009–N–0501; and FDA–2019–N–6098] Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is publishing a SUMMARY: list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A–12M, 11601 Landsdown St., North Bethesda, MD 20852, 301–796–7726, PRAStaff@ fda.hhs.gov. The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at https://www.reginfo.gov/public/do/ PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. SUPPLEMENTARY INFORMATION: TABLE 1—LIST OF INFORMATION COLLECTIONS APPROVED BY OMB OMB control No. Title of collection Food Canning Establishment Registration, Process Filing and Recordkeeping for Acidified and Thermally Processed Low-Acid Foods ......................................................................................................................................... Color Additive Certification Requests and Recordkeeping ..................................................................................... Recordkeeping and Records Access Requirements for Food Facilities ................................................................. Reporting and Recordkeeping Requirements for Reportable Food ........................................................................ Focus Groups as Used by the Food and Drug Administration ............................................................................... Dated: November 25, 2020. Lauren K. Roth, Acting Principal Associate Commissioner for Policy. [FR Doc. 2020–26571 Filed 12–1–20; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2010–N–0190] Agency Information Collection Activities; Proposed Collection; Comment Request; Infant Formula Requirements AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of SUMMARY: VerDate Sep<11>2014 17:39 Dec 01, 2020 Jkt 253001 certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the information collection provisions of our infant formula regulations, including infant formula labeling, quality control procedures, notification requirements, and recordkeeping. The notice also invites comment on electronic Form FDA 3978 that allows manufacturers of infant formula to submit reports and notifications in a standardized format. DATES: Submit either electronic or written comments on the collection of information by February 1, 2021. ADDRESSES: You may submit comments as follows. Please note that late, untimely filed comments will not be PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 0910–0037 0910–0216 0910–0560 0910–0643 0910–0497 Date approval expires 10/31/2023 10/31/2023 10/31/2023 10/31/2023 11/30/2023 considered. Electronic comments must be submitted on or before February 1, 2021. The https://www.regulations.gov electronic filing system will accept comments until 11:59 p.m. Eastern Time at the end of February 1, 2021. Comments received by mail/hand delivery/courier (for written/paper submissions) will be considered timely if they are postmarked or the delivery service acceptance receipt is on or before that date. Electronic Submissions Submit electronic comments in the following way: • Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to https:// www.regulations.gov will be posted to the docket unchanged. Because your comment will be made public, you are solely responsible for ensuring that your comment does not include any E:\FR\FM\02DEN1.SGM 02DEN1

Agencies

[Federal Register Volume 85, Number 232 (Wednesday, December 2, 2020)]
[Notices]
[Pages 77468-77469]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-26533]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-1987-P-0074]


Canned Pacific Salmon Deviating From Identity Standard; Amendment 
of Temporary Marketing Permit

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is amending Bumble Bee 
Seafoods Inc.'s temporary permit to market test canned skinless and 
boneless chunk salmon packed in water that contains sodium 
tripolyphosphate to inhibit protein curd formation during retorting. 
The temporary permit is amended to add an additional manufacturing 
location. This amendment will allow the applicant to continue to test 
market the test product and collect data on consumer acceptance of the 
test product.

FOR FURTHER INFORMATION CONTACT: Marjan Morravej, Center for Food 
Safety and Applied Nutrition (HFS-820), Food and Drug Administration, 
5001 Campus Dr., College Park, MD 20740, 240-402-2371.

SUPPLEMENTARY INFORMATION: In the Federal Register of July 13, 1987 (52 
FR 26186), we issued a notice announcing that we had issued a temporary 
permit to Bumble Bee Seafoods, Inc., San Diego, CA 92123, to market 
test products identified as canned skinless and boneless chunk salmon 
packed in water and containing added sodium tripolyphosphate to inhibit 
protein curd formation during retorting. The permit allowed for the 
test product to be manufactured at a plant located in Petersburg, AK. 
We issued the permit to facilitate market testing of products that 
deviate from the requirements of the standard of identity for canned 
Pacific salmon in 21 CFR 161.170, which were issued under section 401 
of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 341).
    In the Federal Register of April 8, 1988 (53 FR 11710), we issued a 
notice announcing that we had amended the temporary permit to permit 
the test product be manufactured at one additional plant, Chugach 
Alaska Fisheries, Inc., Ocean Dock Rd., Cordova, AK 99574.
    In the Federal Register of September 6, 1988 (53 FR 34354), we 
issued another notice announcing that we were extending the expiration 
date of the permit to either the effective date of a

[[Page 77469]]

final rule for any proposal to amend the standard of identity for 
canned Pacific salmon that may result from the National Food Processors 
Association's petition, submitted on behalf of Bumble Bee Seafoods, 
Inc., and other salmon packers holding temporary permits, or 30 days 
after termination of such proposal.
    In the Federal Register of April 24, 2020 (85 FR 23047), we issued 
a notice announcing that we amended the temporary permit to allow for 
the canned skinless and boneless chunk salmon packed in water with or 
without sodium tripolyphosphate and to allow the test product to be 
manufactured only at one plant, Pataya Food Industries Ltd., located at 
90/6 Moo 7, Settakit Road, Tambol Tarsai, Amphur Maung, Samutsakorn 
74000, Thailand.
    Under our regulations at 21 CFR 130.17(f), we are amending the 
temporary permit issued to Bumble Bee Seafoods, Inc., to allow the test 
product to be manufactured at an additional plant, RS Cannery Company 
Limited, located at 255/1 Industrial Soi 3, Bangpoo Industrial Estate, 
Samutprakarn 10280, Thailand. All other conditions and terms of this 
permit remain the same.

    Dated: November 23, 2020.
Lauren K. Roth,
Acting Principal Associate Commissioner for Policy.
[FR Doc. 2020-26533 Filed 12-1-20; 8:45 am]
BILLING CODE 4164-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.